title: Removal of biologic response modifiers associated with platelet transfusion reactions: strategies worth considering?
authors.affiliation: GIMAP-EA3064, Université de Lyon, Saint-Étienne, France; INTS-Institut National de la Transfusion Sanguine, Paris, France. ogarraud@ints.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Garraud
authors.forename: Fabrice
authors.initials: F
authors.lastname: Cognasse
authors.forename: Hind
authors.initials: H
authors.lastname: Hamzeh-Cognasse
authors.forename: Sherry
authors.initials: S
authors.lastname: Spinelli
authors.forename: Richard P
authors.initials: RP
authors.lastname: Phipps
authors.forename: Neil
authors.initials: N
authors.lastname: Blumberg
mesh_terms: D001787:Blood Group Incompatibility / Q000517:prevention & control*; D001792:Blood Platelets / Q000166:cytology*; D006801:Humans; D007155:Immunologic Factors / Q000302:isolation & purification*; D008863:Microspheres; D017713:Platelet Transfusion / Q000009:adverse effects*
chemical_list: D007155:Immunologic Factors